Persistence of biological agents over an eight-year period in rheumatoid arthritis and spondyloarthritis patients.

CONCLUSIONS: Tocilizumab and etanercept in rheumatoid arthritis, and golimumab in spondyloarthritis and psoriatic arthritis also, were the most persistent drugs in first-line and second-line treatment. PMID: 30624170 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30624170?dopt=Abstract

Source: Farmacia Hospitalaria - January 1, 2019 Category: Drugs & Pharmacology Authors: González-Fernández MÁ, Villamañán E, Jiménez-Nácher I, Moreno F, Herrero A, Balsa A Tags: Farm Hosp Source Type: research